Anke Witting

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease.

Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease.

Journal: Neurochemistry international

Published: March 25, 2017

Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease.

Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease.

Journal: Scientific reports

Published: February 21, 2017

Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.

Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.

Journal: Frontiers in molecular neuroscience

Published: February 06, 2017

High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function.

High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function.

Journal: PloS one

Published: December 20, 2016

Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.

Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.

Journal: Neuropharmacology

Published: November 29, 2016

ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.

ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.

Journal: Neurobiology of disease

Published: May 12, 2016

Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.

Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.

Journal: Acta neuropathologica

Published: October 20, 2015

Peripheral monocytes are functionally altered and invade the CNS in ALS patients.

Peripheral monocytes are functionally altered and invade the CNS in ALS patients.

Journal: Acta neuropathologica

Published: October 02, 2015

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: July 27, 2015

Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.

Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.

Journal: The EMBO journal

Published: July 26, 2015

Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.

Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.

Journal: Acta neuropathologica

Published: June 25, 2015

Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.

Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.

Journal: Neuropharmacology

Published: August 05, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026